Skip to main content
Equibles
VRDN $18.34 +0.33%
VRDN logo
VRDN · Viridian Therapeutics, Inc.\DE
Track VRDN — free

Use VRDN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VRDN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.34 +0.06 (+0.33%) At close · Oct 8
Russell 2000 member Rebalance outlook locked
Market Cap
$2.07B
Shares
113.29M
Volume · Oct 8 2.44M Avg daily vol (3M) 1.71M
All webcasts

Earnings call · FY2025 Q3

Viridian Therapeutics, Inc.\DE (VRDN) Q3 2025 Earnings Call

Concluded Nov 5, 2025
Nov 5, 2025 0 turns
Period
FY2025 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $70.57M +81958.1% YoY
Net income -$34.60M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 5, 2025 10-Q report Filed Nov 5, 2025

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

License$70.00M
Collaboration$570,000 +562.8% YoY
Full-screen source Call document

VRDN transcript alerts

Viridian Therapeutics, Inc.\DE

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →